Stelac Advisory Services LLC Moderna, Inc. Transaction History

Stelac Advisory Services LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $77,456 - $126,398	-343 Closed	0 $0
Q3 2021 Jun 28, 2022	SELL	$221.9 - $484.47 $26,184 - $57,167	-118 Reduced 25.6%	343 $132,000
Q3 2021 Nov 15, 2021	SELL	$221.9 - $484.47 $7,322 - $15,987	-33 Reduced 6.68%	461 $177,000
Q2 2021 Jun 28, 2022	SELL	$129.91 - $234.98 $30,658 - $55,455	-236 Reduced 32.33%	494 $116,000
Q2 2021 Aug 09, 2021	SELL	$129.91 - $234.98 $35,985 - $65,089	-277 Reduced 27.51%	730 $172,000
Q4 2020 Feb 11, 2021	BUY	$65.74 - $169.86 $66,200 - $171,049	1,007 New	1,007 $105,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Stelac Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Stelac Advisory Services LLC with notifications on news.